Published in J Clin Microbiol on August 01, 2005
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother (2005) 3.81
Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol (2007) 2.75
Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis (2007) 2.56
Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol (2007) 1.79
Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol (2009) 1.62
Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol (2009) 1.34
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother (2013) 1.27
Use of fine-needle aspiration for diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol (2010) 1.14
Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue. PLoS Negl Trop Dis (2010) 1.11
Occurrence of free-living amoebae in communities of low and high endemicity for Buruli ulcer in southern Benin. Appl Environ Microbiol (2008) 1.02
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans. Clin Vaccine Immunol (2008) 0.99
"Mycobacterium ulcerans subsp. shinshuense" isolated from a skin ulcer lesion: identification based on 16S rRNA gene sequencing. J Clin Microbiol (2007) 0.98
Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response. Infect Immun (2006) 0.89
Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana. PLoS One (2014) 0.88
Buruli ulcer in United Kingdom tourist returning from Latin America. Emerg Infect Dis (2009) 0.87
Efficiency of fine-needle aspiration compared with other sampling techniques for laboratory diagnosis of Buruli ulcer disease. J Clin Microbiol (2010) 0.85
A quick and cost effective method for the diagnosis of Mycobacterium ulcerans infection. BMC Infect Dis (2012) 0.85
Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo. PLoS Negl Trop Dis (2015) 0.84
Implementation of a national reference laboratory for Buruli ulcer disease in Togo. PLoS Negl Trop Dis (2013) 0.83
Fast and Accurate Large-Scale Detection of β-Lactamase Genes Conferring Antibiotic Resistance. Antimicrob Agents Chemother (2015) 0.82
Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer). J Clin Microbiol (2012) 0.82
Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease. PLoS Negl Trop Dis (2014) 0.80
Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010. J Clin Microbiol (2011) 0.80
Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography. PLoS Negl Trop Dis (2015) 0.80
Genotyping Tools for Mycobacterium ulcerans-Drawbacks and Future Prospects. Mycobact Dis (2014) 0.77
Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review. Can J Infect Dis Med Microbiol (2016) 0.76
Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease. Sci Rep (2015) 0.75
Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis. PLoS Negl Trop Dis (2016) 0.75
Detection of Mycobacterium ulcerans by real-time PCR with improved primers. Trop Med Health (2016) 0.75
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
Avoiding false positives with PCR. Nature (1989) 30.66
Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene (1990) 10.41
A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1994) 5.43
Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol (1997) 3.96
Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol (1999) 3.96
Variability in 3' end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographic origin of isolates. J Clin Microbiol (1996) 3.07
Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1997) 2.50
A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans. J Clin Microbiol (2000) 2.43
Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg (1974) 1.89
Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis (2003) 1.84
Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Br J Dermatol (1966) 1.77
An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease. Trans R Soc Trop Med Hyg (2003) 1.44
Routine application of the polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. J Clin Pathol (1995) 1.40
Development of a polymerase chain reaction dot-blotting system for detecting cutaneous tuberculosis. Br J Dermatol (2000) 1.39
Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol (1999) 1.24
Is PCR a useful tool for the diagnosis of tuberculosis in 1995? Tuber Lung Dis (1995) 1.22
Detection of Mycobacterium tuberculosis in peripheral blood. Lancet (1994) 1.22
Evaluation of the 2-mm punch biopsy in dermatological diagnosis. Clin Exp Dermatol (1996) 0.90
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol (1997) 37.26
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol (1992) 6.08
A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1994) 5.43
The genome of Laccaria bicolor provides insights into mycorrhizal symbiosis. Nature (2008) 5.42
Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae. Clin Exp Immunol (1984) 3.91
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother (2005) 3.81
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg (1998) 3.24
Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet (1991) 3.19
An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res (2001) 3.08
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med (1995) 2.88
Expansion of surveillance case definition for AIDS in resource-poor countries. Lancet (1993) 2.80
T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun (1989) 2.51
Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology (2009) 2.40
An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet (2000) 2.36
Some methodological problems in studying consultations in general practice. J R Coll Gen Pract (1976) 2.33
Clinical research, prophylaxis, therapy, and care for HIV disease in Africa. Am J Public Health (1993) 2.07
Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis (1992) 1.92
Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem (1993) 1.91
Enzyme immunoassay for identification of heat-killed mycobacteria belonging to the Mycobacterium tuberculosis and Mycobacterium avium complexes and derived from early cultures. J Clin Microbiol (1990) 1.81
LAGE-1, a new gene with tumor specificity. Int J Cancer (1998) 1.76
Multiplex PCR assay for immediate identification of the infecting species in patients with mycobacterial disease. J Clin Microbiol (1997) 1.76
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother (2010) 1.72
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
Mycobacterium smegmatis strain for detection of Mycobacterium tuberculosis by PCR used as internal control for inhibition of amplification and for quantification of bacteria. J Clin Microbiol (1994) 1.67
Clinical utility of the polymerase chain reaction in the diagnosis of extrapulmonary tuberculosis. Eur Respir J (1998) 1.64
Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol (2009) 1.62
Factors associated with unconstrained growth among affluent Ghanaian children. Acta Paediatr (2004) 1.56
Factors associated with exclusive breastfeeding in Accra, Ghana. Eur J Clin Nutr (2005) 1.56
Why do patients with ulcerative colitis relapse? Gut (1990) 1.55
Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J Gen Microbiol (1990) 1.54
Suprascapular entrapment neuropathy: a clinical, anatomical, and comparative study. Part 2: anatomical study. Neurosurgery (1979) 1.52
Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry (2000) 1.50
Light emitting diodes for auramine O fluorescence microscopic screening of Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2006) 1.50
Positive predictive value of the UK clinical case definition for H1N1/09 ('swine') influenza. J Infect (2010) 1.50
Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer (1993) 1.49
Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) (2013) 1.49
Sex differences in gallstone pancreatitis. Ann Surg (1991) 1.46
Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol (2000) 1.45
Early diagnosis of tuberculous meningitis by polymerase chain reaction. Neurology (1995) 1.43
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med (1996) 1.42
Leprosy affects the tibial nerves diffusely from the middle of the thigh to the sole of the foot, including skip lesions. Plast Reconstr Surg (2001) 1.42
Vasculitic neuropathy in association with chronic graft-versus-host disease. J Neurol Sci (1999) 1.41
The biliary tract in patients with acute gallstone pancreatitis. Br J Surg (1985) 1.41
Production and characterization of monoclonal antibodies against specific serotypes of Mycobacterium avium and the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex. Infect Immun (1989) 1.40
The potential contribution of the polymerase chain reaction to the diagnosis of tuberculous meningitis. Arch Neurol (1996) 1.39
The autopsy in the 1990s. Br J Hosp Med (1997) 1.39
Metastatic tufted angioma. Int J STD AIDS (1997) 1.39
Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology. Am Rev Respir Dis (1993) 1.38
Development of difference between red and white muscles in sensitivity to Ca2+ in the rabbit from embryo to adult. Nature (1976) 1.31
Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Proc Soc Exp Biol Med (1972) 1.26
Effect of type of haematology analyser on CD4 count. Lancet (1992) 1.26
Diarrhoea associated with cyanobacterium-like bodies: a new coccidian enteritis of man. Lancet (1993) 1.25
Genome sequence of the obligate methanotroph Methylosinus trichosporium strain OB3b. J Bacteriol (2010) 1.24
Detection of Mycobacterium tuberculosis in peripheral blood. Lancet (1994) 1.22
Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides. Antimicrob Agents Chemother (2004) 1.18
Identification and partial purification of an antigen (omega 1) from Schistosoma mansoni eggs which is putatively hepatotoxic in T-cell deprived mice. Trans R Soc Trop Med Hyg (1981) 1.18
Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci (Lond) (1991) 1.17
Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis. Clin Vaccine Immunol (2006) 1.12
Tuberculous lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda. J Clin Pathol (1988) 1.10
A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health (2007) 1.10
Magnetic resonance imaging of the normal and diseased feline middle ear. Vet Radiol Ultrasound (2001) 1.09
Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med (1994) 1.09
Results of the third immunology of leprosy/immunology of tuberculosis antimycobacterial monoclonal antibody workshop. Infect Immun (1992) 1.09
Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun (2006) 1.09
Implication of fatty acids in the inhibitory effect of human adipocytes on osteoblastic differentiation. Bone (2013) 1.08
The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor zeta subunits and the CD3 gamma, delta and epsilon chains. Eur J Immunol (1996) 1.07
Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire. AIDS (1995) 1.05
Some aspects of child health care: contacts between children, general practitioners and school doctors. Community Med (1980) 1.05
Aspergillosis of the nose and paranasal sinuses. J Clin Pathol (1989) 1.04
Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: stage specificity of the reactivity of immune serum in T-cell deprived mice. Trans R Soc Trop Med Hyg (1981) 1.04
Squamous cell carcinoma secondary to Buruli ulcer. Trans R Soc Trop Med Hyg (1999) 1.02
A negative role for phosphoinositide 3-kinase in T-cell antigen receptor function. Curr Biol (1997) 1.02
Opportunistic protozoan infections in human immunodeficiency virus disease: review highlighting diagnostic and therapeutic aspects. J Clin Pathol (1991) 1.01
Necropsies in African children: consent dilemmas for parents and guardians. Arch Dis Child (2001) 1.00
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans. Clin Vaccine Immunol (2008) 0.99
Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl (2011) 0.98
Rapid identification of cultured Mycobacterium tuberculosis with a panel of monoclonal antibodies in western blot and immunofluorescence. Res Microbiol (1990) 0.98
Stabilized, freeze-dried PCR mix for detection of mycobacteria. J Clin Microbiol (1998) 0.97
Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine (1990) 0.96